The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world treatment outcomes of first-line axitinib plus pembrolizumab in patients with advanced renal cell carcinoma in the United States.
 
Yousef Zakharia
Consulting or Advisory Role - Amgen; Bayer; Cardinal Health; Castle Biosciences; Clovis Oncology; Eisai; EMD Serono; Exelixis; Janssen; Novartis; Pfizer; Roche/Genentech; Seagen; TTC Oncology
Research Funding - Eisai (Inst); Exelixis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Newlink Genetics
 
Despina Thomaidou
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Benjamin Li
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Gordan Siu
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Rebecca Levin
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Anna Vlahiotis
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Giovanni Zanotti
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer